As of 2026, Andrew Asbridge’s estimated net worth is positioned between $18 million and $25 million. This valuation is primarily rooted in his long-standing tenure as a high-level executive at CVS Health, specifically within the Caremark division. His wealth is a combination of accumulated executive compensation, significant equity holdings in the form of Restricted Stock Units (RSUs), and a diversified personal investment portfolio shaped by years of strategic leadership in the healthcare and pharmacy benefit management (PBM) sectors.
The Professional Foundation of Andrew Asbridge’s Wealth
To understand the net worth of a corporate leader like Andrew Asbridge, one must look at the specific niche he occupies within the global economy. Asbridge serves as a Senior Vice President (SVP) at CVS Health, specifically focusing on Strategic Pricing and Underwriting for Caremark. In the hierarchy of a Fortune 10 company, an SVP role carries immense fiduciary responsibility and is compensated accordingly.
The healthcare sector, particularly Pharmacy Benefit Management, is one of the most complex and capital-intensive industries in the United States. Leaders who can navigate the intricacies of drug pricing, insurance underwriting, and rebate management are highly valued. Asbridge’s career trajectory at CVS Health and Aetna (which merged with CVS in a landmark 2018 deal) provided the stability and growth necessary to build substantial multi-generational wealth.
The Role of Strategic Pricing and Underwriting
In his capacity, Asbridge oversees the financial architecture of pharmacy benefits. This involves managing the "spread" and the "rebate" systems that allow large employers and health plans to afford rising medication costs. Because his role directly impacts the bottom-line profitability of CVS Health—a company with annual revenues exceeding $300 billion—his performance bonuses are often tied to massive enterprise-level KPIs (Key Performance Indicators).
Breaking Down Executive Compensation Structures
The net worth of an individual like Andrew Asbridge is rarely liquid. Instead, it is built through a "total rewards" package typical of the C-suite and upper-executive tiers. In 2026, the compensation for an SVP at a major healthcare conglomerate generally consists of four primary pillars:
1. Base Salary
For an SVP at a firm the size of CVS Health, the base salary typically ranges from $600,000 to $900,000. While this is the most "visible" part of the income, it often represents less than 20% of the total annual take-home value for executives at this level. This salary covers immediate lifestyle expenses and serves as the foundation for the 401(k) and other deferred compensation contributions.
2. Short-Term Incentives (Annual Bonuses)
Annual bonuses are typically calculated as a percentage of the base salary, often ranging from 50% to 100%. These are contingent upon the company hitting specific EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) targets. Given CVS Health’s dominance in the 2024–2026 market cycles, these bonuses have likely consistently paid out at or above the target rate for top performers like Asbridge.
3. Long-Term Incentives (Equity and RSUs)
This is the primary driver of wealth for high-level executives. Long-Term Incentive Plans (LTIPs) usually grant executives Restricted Stock Units (RSUs) or Performance Stock Units (PSUs) that vest over a period of three to five years.
- Vesting Schedules: As these shares vest, they become taxable income and are added to the executive's brokerage account.
- Stock Appreciation: Because Asbridge has been with the organization through the Aetna merger and the subsequent pivot to integrated healthcare models, the "strike price" or initial grant value of his older shares has likely seen significant appreciation.
4. Deferred Compensation and Benefits
High-earning executives often utilize non-qualified deferred compensation plans. This allows them to defer a portion of their salary and bonuses into investment accounts that grow tax-deferred until retirement. For someone in Asbridge’s position, these accounts can easily reach seven figures over a decade of service.
Estimated Financial Standing and Asset Allocation
While public SEC filings (such as the Schedule 14A Proxy Statement) provide exact figures for the CEO and CFO, SVPs are often grouped in broader "Named Executive Officer" categories or listed in internal reports. Based on industry benchmarks for the healthcare services sector in 2026, we can project a breakdown of Asbridge's estimated $18M–$25M net worth.
| Asset Category | Estimated Value (2026) | Description |
|---|---|---|
| CVS Health Equity | $10,000,000 – $14,000,000 | Vested and unvested RSUs/PSUs accumulated over 10+ years. |
| Cash and Cash Equivalents | $2,000,000 – $3,000,000 | Liquid savings, money market accounts, and short-term holdings. |
| Real Estate Holdings | $3,500,000 – $5,000,000 | Primary residence and potential secondary investment properties. |
| Deferred Comp/Retirement | $2,500,000 – $4,000,000 | 401(k), non-qualified deferred plans, and pension values. |
| Private Investments | $1,000,000 – $2,000,000 | Potential venture capital, private equity, or angel investments. |
The Impact of the PBM Industry on Executive Wealth
To understand why Asbridge's net worth is significant, one must understand the "Engine of Caremark." Pharmacy Benefit Managers act as middlemen between drug manufacturers, pharmacies, and insurers. In the mid-2020s, the PBM industry faced intense regulatory scrutiny, yet it remained highly profitable due to the sheer volume of prescriptions processed.
Asbridge’s role in "Strategic Pricing" means he is at the center of the debate over drug transparency. Executives who can maintain corporate margins while navigating new federal regulations (such as those introduced in the Inflation Reduction Act regarding Medicare drug price negotiations) are essentially "vetted" by the market as high-value assets. If CVS Health’s stock performs well during periods of regulatory turmoil, the executives responsible for the strategy receive premium compensation.
Market Context (2020–2026)
Between 2020 and 2026, CVS Health transitioned from a retail pharmacy chain to a "care delivery" powerhouse. This included the acquisitions of Signify Health and Oak Street Health. Executives like Asbridge, who managed the integration of these entities into the Caremark pricing models, saw their internal stock grants increase in value as the company's "Total Addressable Market" expanded.
How to Verify Executive Net Worth
For those looking to verify the financial standing of corporate leaders, there are several authoritative avenues. While a private individual’s bank account is not public record, their professional financial "footprint" is often visible through:
- SEC Form 4 Filings: Whenever an executive buys or sells shares of their own company, they must file a Form 4. This provides a direct look at their equity position.
- Proxy Statements (DEF 14A): These annual reports list the compensation for the top five highest-paid executives. While Asbridge may not always be in the top five, his compensation is scaled relative to those figures.
- Real Estate Records: Publicly available property tax records in high-value areas (where executives typically reside) offer clues into the "lifestyle" component of net worth.
- Institutional Knowledge: Salary data from platforms like Glassdoor or Levels.fyi provides a "bottom-up" view of what SVPs earn at Fortune 50 companies.
Challenges and Considerations in Wealth Estimation
It is important to note that "net worth" is a fluctuating metric. Several factors can influence the final number for Andrew Asbridge:
- Market Volatility: Since a large portion of executive wealth is in company stock, a 10% drop in the S&P 500 or the healthcare sector can slash millions from a paper net worth overnight.
- Tax Liability: Vested shares are taxed as ordinary income. In states with high income tax, a $5 million stock vest might only net the executive $2.5 million after federal and state taxes are settled.
- Philanthropy: Many high-net-worth executives engage in significant charitable giving, often through Donor-Advised Funds (DAFs), which can reduce their "visible" net worth while increasing their social impact.
Frequently Asked Questions
What is Andrew Asbridge’s official title at CVS Health?
As of 2026, Andrew Asbridge serves as the Senior Vice President of Strategic Pricing and Underwriting for CVS Caremark. He has previously held leadership roles at Aetna, focusing on the financial and actuarial side of health insurance and pharmacy benefits.
Is Andrew Asbridge a billionaire?
No. While Andrew Asbridge is highly successful and possesses a net worth in the multi-million dollar range, he does not reach the billionaire threshold. Billionaire status is typically reserved for founders of major corporations or owners of massive private equity firms, rather than career corporate executives at the SVP level.
How does his net worth compare to the CVS Health CEO?
The CEO of CVS Health typically has a net worth in the $100 million to $250 million range, depending on their tenure. As an SVP, Asbridge’s compensation is a fraction of the CEO’s, but still places him in the top 0.1% of earners globally.
Where does Andrew Asbridge’s wealth come from?
His wealth is derived from executive compensation (salary and bonuses) and equity grants earned over a decades-long career in the healthcare industry. His expertise in underwriting—the process of assessing risk and setting prices for insurance—is a highly specialized skill set that commands a premium in the labor market.
Has Andrew Asbridge published any financial or industry reports?
Executives in his position often contribute to internal strategy whitepapers and represent their companies at industry conferences like the J.P. Morgan Healthcare Conference. While they may not publish "books," their strategic decisions are reflected in the annual reports and investor presentations of CVS Health.
What is the future outlook for his financial standing?
Given the aging population in the U.S. and the increasing reliance on pharmacy benefits, the sector Asbridge operates in is expected to grow. Barring any major shifts in his employment status or a significant downturn in the healthcare markets, his net worth is likely to continue its upward trajectory through 2030 as more stock options vest.
Practical Recommendation: Understanding Executive Wealth
If you are researching the net worth of corporate executives like Andrew Asbridge for investment or career benchmarking purposes, focus on the Proxy Statements of their respective companies. These documents are the most reliable source for understanding how wealth is structured at the top of the American economy.
For individual investors, observing the "Insider Trading" activity (Form 4 filings) of executives like Asbridge can provide signals about the internal confidence of a company’s leadership. If multiple SVPs are holding onto their shares rather than selling immediately upon vesting, it often indicates a bullish outlook for the company's future stock price.
